Clinical Trial Update: Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating glofitamab in mantle cell lymphoma patients who had inadequate response or relapse after CAR-T therapy; the study is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Glofitamab (glofitamab)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING